Home       Market Dynamics     Macro Trends     Sector Trends     Company Insights     AI Investing     Strategies     Sign Up     Login         

Eli Lilly (LLY) Stock Price Prediction and News Highlight
Fri. Apr 24, 2026

One Week Return: -4.6%, One Month Return: -2.03%, Three Month Return: -16.92%

Sector: Pharmaceuticals

Eli Lilly is making significant strides in product and service development, particularly through its recent $7 billion acquisition of Kelonia Therapeutics, which enhances its capabilities in oncology and genetic medicine. The approval of the GLP-1 weight loss pill, Foundayo, alongside the commitment to expand cancer treatment options, reflects a positive trend in both innovation and market positioning. However, concerns about the effectiveness of Alzheimer's drugs pose challenges in maintaining trust in their product offerings. Overall, while there are promising advancements, the company faces hurdles in addressing therapeutic efficacy in certain areas.

The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -1.6 is very bearish. The market sentiment at 0.6 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 1, and the negative at -0.4 on 2026-04-24. The forces of Stock Price Trend (-1.6), and Sector Price Trend (-1.4) will drive down the price. The forces of Price Level Sentiment (0.5), Option Sentiment (0.8), Market Risk Appetite (1), Valuation Sentiment (1.4), and Sentiment towards Fundamentals (2.3) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-04-30 06:30, EPS: $22.94, P/E: 38.54

Sign up to reveice notifications on Market Movers
LLY
DateAttentionPriceStdDevPrice
Level
Change10 Day
Trend
Trend
Sentiment
Hourly
Trend
Sentiment
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2026-04-241%(0.4%)      884.18 2.45%    8    -3.6%    -0.6% -1.6    -0.5    2%    0.6    Short    55% 2.3    -1.8   
2026-04-230%(0.3%)      917.23 2.27%    45    -0.46%    -0.41% -0.1    0    0.7%    1.2    Long    55% 2.6    -1   
2026-04-220%(0.3%)      921.5 2.26%    50    2.03%    -0.35% 0.1    0.3    1.2%    1.4    Long    55% 2.7    5.7   
2026-04-210%(0.3%)      903.19 2.35%    30    -1.96%    -0.3% -0.7    -0.2    1.4%    0.8    Short    55% 2.5    -1   
2026-04-201%(0.3%)      921.27 2.28%    51    -0.6%    -0.05% -0.2    -0.1    0.9%    1.5    Short    55% 2.2    6.2   
2026-04-191%(0.1%)    -0.4    -0.1    1          1.4    5.5   
2026-04-180%(0%)    -0.4    -0.1    1          1.4    -1   
2026-04-170%(0%)      926.79 2.29%    58    2.59%    -0.1% -0.4    0.5    1.1%    1.1    Long    55% 1.7    4   
2026-04-160%(0%)      903.43 2.34%    31    -0.19%    -0.55% -1.8    -0.4    1.2%    0.6    Short    65% 1.1    5.5   
2026-04-150%(0%)      905.13 2.3%    32    -1.94%    -0.16% -1.3    -0.5    1.5%    0.7    Short    55% 1.8    -5.5   
 
Short is the preferred trading strategy with 55% chance of being right. Weak trend sentiment and negative hourly trend.

Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.

Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

  Analysis
Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026

2026-04-24 17:02:13 Analysts' projections indicate a potential upward valuation for Eli Lilly, suggesting a good investment opportunity despite current stock price pressures.
2026-04-24 17:02:13 Eli Lilly boasts competitive advantages in manufacturing and potential market strategies that may provide long-term value despite current challenges.
2026-04-24 17:02:13 Despite initial performance challenges, Eli Lilly's new obesity pill, Foundayo, shows promise with a substantial number of prescriptions in its second week.
2026-04-24 17:02:13 Eli Lilly faces significant competition from Novo Nordisk in the obesity treatment market, impacting its product uptake and market perception.
2026-04-24 17:02:13 Eli Lilly's stock has shown a decline in performance, notably with a notable drop of -3.6%, indicating investor concerns about its market position.
2026-04-24 13:48:09 Eli Lilly's stock is experiencing a downturn, reflecting potential investor concerns regarding its relevance in the weight-loss drug market amid rising competition.
2026-04-24 13:48:09 The ongoing development of weight-loss products like Eli Lilly’s and Novo's Wegovy indicates a significant focus and investment in this segment of the healthcare market.
2026-04-24 13:48:09 Analysts express that concerns regarding Eli Lilly’s market position relative to Wegovy are considered overblown, indicating a nuanced perspective on stock performance.
2026-04-24 13:48:09 Eli Lilly's weight-loss pill is facing stiff competition from Novo's Wegovy, highlighting the competitive landscape in the weight-loss pharmaceutical market.
2026-04-24 11:49:07 Intense competition among health and pharmaceutical companies, particularly in the weight loss drug sector.
2026-04-24 11:49:07 JPMorgan's initiation of coverage on Hims & Hers Health stock, indicating potential confidence in the company's market performance.
2026-04-24 11:49:07 The stock performance of Eli Lilly and its new GLP-1 weight-loss drug, amid disappointing prescription data compared to competitors such as Novo Nordisk's Wegovy.
2026-04-24 09:34:00 The initial prescription rates for Eli Lilly's new obesity pill indicate a positive but cautious reception in the market.
2026-04-24 09:34:00 The competitive landscape of obesity treatments, specifically between Eli Lilly and Novo Nordisk, highlighting the early challenges faced by Lilly's new product.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA